- PRISTINE SAFETY PROFILE
- Compatible with most therapeutics and potential use as adjunct therapy.
- Candidate Predictive Biomarkers
- Potential for simultaneous therapeutic support of common comorbidities like diabetes.
AQABELA LTD (UK) & AQABELA.EU SIA (Latvia)